Brief: Bioventus Receives FDA 510(K) Clearance For SonaStar Elite
03/08/2022 12:16
Aug 3 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS RECEIVES FDA 510(K) CLEARANCE FOR SONASTAR ELITE
Source text for Eikon: ID:nGNXv7sNm
Further company coverage: BVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks